Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Anxiety
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Anxiety
    TopAbstracts in Anxiety 10/28/2009 - (DGNews)
    TopAbstracts in Anxiety 10/14/2009 - (DGNews)
    TopAbstracts in Anxiety 09/30/2009 - (DGNews)
    Adjunctive Pregabalin Benefits Patients With Treatment-Resistant Generalised Anxiety Disorder: Presented at ECNP - (DGDispatch)
    Pregabalin Facilitates Successful Switch From Benzodiazepine Therapy in Patients With Generalised Anxiety Disorder: Presented at ECNP - (DGDispatch)

    News archive

     Recent webcasts/CME - Anxiety

    Webcasts/CME archive

     Recent cases - Anxiety
      Diagnosing and Managing Post-Traumatic Stress Disorder
      Chronic Dizziness Presenting in a Patient with Panic Disorder: Response to Imipramine
      Aripiprazole Augmentation in Poor Insight Obsessive-Compulsive Disorder: A Case Report
      Recurrence of Suicidal Ideation Due to Treatment with Antidepressants in Anxiety Disorder: A Case Report
      Persistent Tardive Rebound Panic Disorder, Rebound Anxiety and Insomnia Following Paroxetine Withdrawal: a Review of Rebound-Withdrawal Phenomena

      Cases archive
        




      my personal edition > anxiety > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Agoraphobia Treatment May Not Necessary In Patients Treated For Panic Disorder

      A DGReview of :"Panic control treatment for agoraphobia"
      Journal of Anxiety Disorders

      05/20/2003
      By Emma Hitt, PhD


      In patients diagnosed with panic disorder and agoraphobia, a reduction in panic frequency appears to predict a reduction in symptoms of agoraphobia; therefore, targeted treatment for agoraphobia may not be necessary when patients are being treated for panic disorder.

      Previous studies have demonstrated a strong association between the occurrence of panic attacks and agoraphobia. Michelle G. Craske, PhD, with the University of California Los Angeles, and colleagues evaluated whether treatment for panic attacks alone may be sufficient for improving symptoms of agoraphobia.

      The researchers evaluated 68 individuals, 18 to 55 years of age, who met the diagnosis for panic disorder with agoraphobia. Participants were randomly assigned to treatment with 90-minute weekly sessions of either panic control therapy only or panic control with agoraphobia therapy (in vivo exposure) for 16 weeks. Agoraphobia treatment included extensive discussion about the method of in vivo exposure and application of panic control strategies to in vivo exposure.

      Patients were assessed at baseline, mid-treatment, post treatment, and 6-months later. Panic and agoraphobia were both evaluated using ADIS-IV (Anxiety Disorder Interviews Schedule for DSM-IV) ratings as well as measures of behavioral, physiological, and subjective anxiety responses. Functionality was measured with a 0 to 8 rating of severity of distress and disablement.

      The researchers found that the two treatments were equally efficacious for both panic disorder and agoraphobia.

      Dr. Craske and colleagues provide two explanations for their findings: 1) once an individual learns to no longer fear the symptoms of panic, then hesitation about entering agoraphobic situations naturally subsides, and 2) participants who received the panic control only treatment may take it upon themselves to conduct their own in vivo exposure therapy.

      "Overall rates of success are on par with other studies involving more severely agoraphobic patient samples treated in a weekly cognitive-behavioral group format," the researchers point out.

      "The findings suggest that structured in vivo exposure therapy, involving a hierarchy of agoraphobic situations, detailed instruction and rehearsal, specific graduated in vivo exposures, and weekly corrective feedback does not significantly improve the outcome from panic control treatment," they conclude.
      J Anxiety Disord 2003;17:3:321-33. "Panic control treatment for agoraphobia"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send